Endocyte Pursuing Phase 3 Trial of 177Lu-PSMA-617 in Metastatic PC
Patrick posted a video of this treatment a few days ago. I wonder if any of the Phase 3 trials will be in the US:
177Lu-PSMA-617 - ncbi.nlm.nih.gov/pubmed/270... 2. Bipolar Androgen Therapy - www...
Ac-225-PSMA-617 is an alpha particle emitter that targets prostate cancer cells. Lu-177-PSMA-617 is a beta...
Start a Community